EUVIMEDEUVIMED entdecken
Crossref

Ding-zhi-xiao-wan attenuates Alzheimer’s disease pathology and cognitive deficits in mouse model

Zhulei Miao, Zhiling Yang, Qilin Huang, Jianhua Fan, Jinxia Sun, Lixin Wang, Yuejuan Zheng, Guizhen Yang

Brain Research · 2026

DOI: 10.1016/j.brainres.2026.150263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2026. Verfasst von Zhulei Miao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, School of Integrative Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, S…. Hauptthemen laut MEDLINE: Alzheimer Disease, Drugs, Chinese Herbal, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shanghai University of Traditional Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ding-zhi-xiao-wan (DZXW) is a classic prescription applied for the therapy of forgetfulness and dizziness. However, the mechanisms of DZXW in ameliorating cognition deficits in Alzheimer's disease (AD) have not been fully determined. To comprehensively illuminate the overall beneficial effects and the underlying molecular mechanisms of DZXW to AD. METHODS: An initial network pharmacology analysis was performed, including of construction of multiple networks and enrichment of gene ontology, and analysis of signal pathway. Furthermore, animal experiments were performed to validate the predicted molecular mechanisms from network pharmacology. RESULTS: 39 active compounds in DZXW corresponding to 224 genes related to AD protection were found. The therapeutic mechanisms of DZXW to protect AD predicted from the network pharmacology were primarily related to the negative regulation of neuroinflammation and oxidative stress. Compared to AD model mice, DZXW-administeredmice explored new objects more often, demonstrated a significantly shorter escape latency, passed through the platform more frequently, and stayed in the platform quadrant longer. Furthermore, DZXW-administeredmice showed a markedly less burden of Aβ plaques, lower number of activated microglias in the mice brain, enhanced activity of superoxide dismutase (SOD) and glutathione (GSH), and lower level of malondialdehyde (MDA) in mice. CONCLUSIONS: DZXW could be a therapeutic candidate for AD by inhibiting neuroinflammation and oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrugs, Chinese HerbalCognitive DysfunctionAnimalsDisease Models, AnimalMiceOxidative StressMaleBrainAmyloid beta-PeptidesPlaque, AmyloidNetwork PharmacologyMice, Inbred C57BL

Stichwörter der Autor:innen

Alzheimer’s diseaseDing-zhi-xiao-wanNeuroinflammationOxidative stressPharmaceutical bio-informatics

Substanzen

Drugs, Chinese HerbalAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Immunology and Microbiology, School of Integrative Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Department of Traditional Chinese Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
  • Guangxi University of Chinese Medicine, Nanning, Guangxi 530200, China.
  • Department of Internal Medicine, Huangpu Branch, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China.
  • Center for Traditional Chinese Medicine and Immunology Research, School of Integrative Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: 13641…
  • Department of Immunology and Microbiology, School of Integrative Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: yanggzliuch@163.com.

Förderung

  • Shanghai University of Traditional Chinese Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Miao, Z., Yang, Z., Huang, Q., Fan, J., Sun, J., Wang, L., Zheng, Y., & Yang, G. (2026). Ding-zhi-xiao-wan attenuates Alzheimer’s disease pathology and cognitive deficits in mouse model. Brain Research. https://doi.org/10.1016/j.brainres.2026.150263

Vancouver

Miao Z, Yang Z, Huang Q, Fan J, Sun J, Wang L, et al. Ding-zhi-xiao-wan attenuates Alzheimer’s disease pathology and cognitive deficits in mouse model. Brain Research. 2026. doi:10.1016/j.brainres.2026.150263

BibTeX
@article{Miao2026,
  author = {Miao, Zhulei and Yang, Zhiling and Huang, Qilin and Fan, Jianhua and Sun, Jinxia and Wang, Lixin and Zheng, Yuejuan and Yang, Guizhen},
  title = {Ding-zhi-xiao-wan attenuates Alzheimer’s disease pathology and cognitive deficits in mouse model},
  journal = {Brain Research},
  year = {2026},
  doi = {10.1016/j.brainres.2026.150263}
}
Kostenlos starten →